CoChat

A Meta-Analysis of Oxidative Stress Markers in Depression

Open access

The DOI matches its Crossref record; 124 of the 125 references it cites were found in a registry or an index.

Abstract

OBJECT: Studies have suggested that depression was accompanied by oxidative stress dysregulation, including abnormal total antioxidant capacity (TAC), antioxidants, free radicals, oxidative damage and autoimmune response products. This meta-analysis aims to analyse the clinical data quantitatively by comparing the oxidative stress markers between depressed patients and healthy controls. METHODS: A search was conducted to collect the studies that measured the oxidative stress markers in depressed patients. Studies were searched in Embase, Medline, PsychINFO, Science direct, CBMDisc, CNKI and VIP from 1990 to May 2015. Data were subjected to meta-analysis by using a random effects model for examining the effect sizes of the results. Bias assessments, heterogeneity assessments and sensitivity analyses were also conducted. RESULTS: 115 articles met the inclusion criteria. Lower TAC was noted in acute episodes (AEs) of depressed patients (p<0.05). Antioxidants, including serum paraoxonase, uric acid, albumin, high-density lipoprotein cholesterol and zinc levels were lower than controls (p<0.05); the serum uric acid, albumin and vitamin C levels were increased after antidepressant therapy (p<0.05). Oxidative damage products, including red blood cell (RBC) malondialdehyde (MDA), serum MDA and 8-F2-isoprostanes levels were higher than controls (p<0.05). After antidepressant medication, RBC and serum MDA levels were decreased (p<0.05). Moreover, serum peroxide in free radicals levels were higher than controls (p<0.05). There were no differences between the depressed patients and controls for other oxidative stress markers. CONCLUSION: This meta-analysis supports the facts that the serum TAC, paraoxonase and antioxidant levels are lower, and the serum free radical and oxidative damage product levels are higher than controls in depressed patients. Meanwhile, the antioxidant levels are increased and the oxidative damage product levels are decreased after antidepressant medication. The pathophysiological relationships between oxidative stress and depression, and the potential benefits of antioxidant supplementation deserve further research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0138904

Cites

124 of 124 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 The comparisons of effect sizes for serum TAC (A), serum non-enzymatic antioxidants (B), red blood cell enzymatic antioxidants (C), serum enzymatic antioxidants (D), serum free radicals (E) and serum oxidative damage products (F) in acute episodes between depressed patients and controls (red bar) and in comparison before and after treatment of depressed patients (yellow bar). Positive effect sizes (bars go upwards) indicate that the marker levels in depressed patients were higher than controls or increased after antidepressant therapy; negative effect sizes (bars go downwards) indicate that marker levels were lower than controls or decreased after antidepressant therapy. *p < 0.05, **p < 0.01, ***p < 0.001. TAC, total antioxidant capacity; HDL-C, high-density lipoprotein cholesterol; SOD, superoxide dismutase; GPX, glutathione peroxidase; CAT, catalase; GR, glutathione reductase; PON, paraoxonase; MDA, malondialdehyde; 8-iso-PGF2α, 8-F2-isoprostanes; PCC, oxidation protein product.
Fig 1 The comparisons of effect sizes for serum TAC (A), serum non-enzymatic antioxidants (B), red blood cell enzymatic antioxidants (C), serum enzymatic antioxidants (D), serum free radicals (E) and serum oxidative damage products (F) in acute episodes between depressed patients and controls (red bar) and in comparison before and after treatment of depressed patients (yellow bar). Positive effect sizes (bars go upwards) indicate that the marker levels in depressed patients were higher than controls or increased after antidepressant therapy; negative effect sizes (bars go downwards) indicate that marker levels were lower than controls or decreased after antidepressant therapy. *p < 0.05, **p < 0.01, ***p < 0.001. TAC, total antioxidant capacity; HDL-C, high-density lipoprotein cholesterol; SOD, superoxide dismutase; GPX, glutathione peroxidase; CAT, catalase; GR, glutathione reductase; PON, paraoxonase; MDA, malondialdehyde; 8-iso-PGF2α, 8-F2-isoprostanes; PCC, oxidation protein product.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 124 references

Research works printed but not linked: 32

  1. N Bal, 2012, Altered Levels of Malondialdehyde and Vitamin E in Major Depressive Disorder and Generalized Anxiety Disorder, Dusunen Adam: Journal of Psychiatry & Neurological Sciences, 25, 206
  2. ZP Qian, 2012, A study of correlation between serum zinc and lithium levels of depressed patients, Medical Laboratory Science and Clinics, 23, 64
  3. Y Chen, 2010, A study of serum IL-1β, IL-6 and blood SOD levels in patients of depression, Neural Injury and Functional Reconstruction January, 5, 74
  4. JM Hu, 1996, Analysis of superoxide dismutase activity of red blood cell in patients with schizophrenia and depression, Chinese Journal of Nervous and Mental Diseases, 22, 86
  5. ZZ Huang, 1999, Study on lipid peroxide, superoxide dismutase and glutathione peroxidase in patients with affective disorder, Chin J Psychiatry, 32, 191
  6. J He, 2000, The clinical study of antioxidative capacity in psychiatry patients, Chinese Journal of Behavio ral Medical Science, 9, 139
  7. XH Zhang, 1997, Changes of plasma SOD activity and MDA level in patients with depression and anxiety, Journal of Convalescen and Rehabilitation, 12, 157
  8. SL Wen, 2013, Analysis on serum levels of non-enzyme antioxidants and intelligence quotient in patients with recurrent depression, Chin Prev Med, 14, 579
  9. MF Chen, 2010, Analysis on serum levels of uric acid in patients with depression, Chin J Prev Chron Dis, 18, 302
  10. MF Chen, 2012, Plasma Non-enzyme Antioxidants Levels in the Depressive Patients with Attempted Suicide, Chin J Prev Chron Dis, 20, 529
  11. J Lu, 2010, The effect of escitalopram on serum glucose and lipids, Medical Journal of Chinese People’s Health, 22, 2242
  12. YG Yuan, 2002, Serum lipid concentrations in patients with comorbid anxiety and depression, Chin J Nerv Ment Dis, 28, 33
  13. YG Yuan, 2006, A study of serum lipid concentrations and apolipoprotein E genotype among patients with senile depression and alzhemier disease, Chinese General Practice, 9, 106
  14. YG Yuan, 2003, The relation ship between plasma monoamine neurotransmitters and serum lipid concentrations in depressive patients, J Clin Psychol Med, 13, 67
  15. XB Huang, 2003, Serum lipid and catecholamin concentrations in patients with anxiety and depression, J Clin Psychol Med, 13, 94
  16. MD Wu, 2004, A study of serum lipid concentrations in 536 patients of psychiatric disorders, Journal of Sichuan Continuing Education College of MS, 23, 175
  17. XH Wang, 2014, A study of physical function, serum lipids and cytokines in 48 uygur elderly patients with depression, Xinjiang Medical Journal, 44, 61
  18. YC Lv, 2011, Analysis of suicidal behavior and detection of biological parameter in patients with depressive disorder, Journal of Medical Forum, 32, 7
  19. GH Wang, 2003, The levels of the cholesterol, triglyceride, lipoprotein, apolipoprotein in young depression patients, MedicaI JournaI of Wuhan University, 24, 174
  20. RP Che, 2014, The study on lipid metabolism in 86 patients with first episode depression, Journal of Practical Medical Techniques, 21, 664
  21. WJ Zhang, 2012, The clinical study of serum thyroid hormone and lipid levels in patients with first episode depression, Chin J Lab Diagn, 16, 712
  22. QC Xia, 2009, Study of metabolism of glucose and lipid in patients of first-episode depressioon, J Clin Psychiatry, 19, 241
  23. CY Li, 2011, The comparative study on serum glucose and lipids in patients with first episode depression, Medical Journal of ChinesePeople’s Health, 23, 1355
  24. WL He, 2013, Research on lipid metabolism of the first-episode patients with depression, World Health Digest Medical Periodieal, 10, 413
  25. YM Jiao, 2006, Fasting blood glucose and serum lipid level in patients with major depression and their relations to psychopathology, Shanghai Archives of Psychiatry, 18, 266
  26. FX Wu, 1998, Depression and hemorheology, J Clin Psychol Med, 8, 341
  27. HY Yu, 1997, The mearsure of trace element in red blood cell and serum of depressed patients, Hebei Mental Health, 10, 10
  28. MD Fernández-González, 1998, Trace elements in serum of psychiatric outpatients, Química Clínica, 17, 208
  29. XR Chang, 2001, The mearsure of serum 14 kinds of trace element in patients of depression, Chinese Journal of Behavioral Medical Science, 10, 589
  30. XQ Guo, 2011, A study of serum ten kinds of trace element level changes in depressed patients, China Health Monthly, 1, 136
  31. GF Wu, 2012, A study of correlation between cytokine, serum zinc level, thyroid hormone and depression, The Public Health, 6, 61
  32. XW Xu, 2010, The mearsure of MAO, MDA, hs-CRP levels and their clinical meaning in patients of depression, Medical Innovation of Chin, 7, 175

Cited by

See all 485

Metadata

Authors
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y.
Affiliations
Jinan University (CN)
Corresponding author
Jia, Yanbin
Venue
PLOS ONE
Published
2015-10-07
Volume
10
Issue
10
Pages
e0138904
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2105160377
Cited by
485
References
125
Citations by year
2026: 30 · 2025: 41 · 2024: 42 · 2023: 54 · 2022: 51 · 2021: 78 · 2020: 63 · 2019: 39 · 2018: 43 · 2017: 27 · 2016: 15
FWCI
2.99
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Jinan University
  • Department of Education of Guangdong Province
Topics
  • Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
depression, oxidative stress, total antioxidant capacity, antioxidants, paraoxonase, uric acid, malondialdehyde, 8-isoprostane, free radicals, oxidative damage, antidepressant treatment, acute depressive episode, antioxidant supplementation
MeSH terms
Albumins, Antidepressive Agents, Antioxidants, Ascorbic Acid, Cross-Sectional Studies, Depression, Depressive Disorder, Humans, Lipoproteins, HDL, Malondialdehyde, Uric Acid, Lipid Peroxidation, Biomarkers, Case-Control Studies, Oxidative Stress, F2-Isoprostanes, Aryldialkylphosphatase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Meta-Analysis of Oxidative Stress Markers in Depression. https://app.cochat.ai/papers/10.1371/journal.pone.0138904
The paper
Liu, T., Zhong, S., Liao, X., Chen, J., He, T., Lai, S., & Jia, Y. (2015). A Meta-Analysis of Oxidative Stress Markers in Depression. PLOS ONE. https://doi.org/10.1371/journal.pone.0138904

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.